EDL joins Abenex to develop

The founders of EDL, a leading software provider for medical imaging services, join forces with Abenex to boost its development

Jean Lordet, Alain Lopez and Jean-Louis Marx have partnered in Edition et Développement Logiciels (“EDL”) since 1993, creating the leading software vendor for the medical imagery department for both public and private organizations in France.

The three founders welcome Abenex as a new shareholder of EDL. The transaction aims at accelerating the Group’s development while reinforcing its governance and strengthening its capital.

With its Xplore software, EDL offers its customers a fully modern, integrated and SaaS-ready solution which facilitates information sharing and improves the performance of medical imaging departments. Xplore is praised for its ergonomics, its wide set of functionalities and its proven robustness. The solution notably enables an efficient roll-out of tele-radiology within multi-site organizations as well as swift communication flows between radiology departments and the complex medical environment with which it interacts on a daily basis.

Supported by Abenex, EDL will pursue its organic growth strategy by further capitalizing on the quality and technological edge of its software solutions. Already present in Switzerland (since 2000) and Germany (since 2018, following the acquisition of the local player Penta), EDL aims at continuing its international development through targeted acquisitions.

Jean Lordet, Alain Lopez and Jean-Louis Marx, founders and executives of EDL: “We were convinced by the enriching dialogue and the trust-based relationship we quickly built with Abenex. Abenex will support us in our external growth strategy and in structuring the company following Jean-Louis Marx’s stepping back from its operational tasks. Abenex will help us to strengthen our position as a major player in technological innovation for healthcare services.”

Antoine Schouman and Jérôme Vandermarcq, Partners at Abenex: “Positioned on a dynamic market, EDL has been building an undisputed leading position thanks to its unique technological know-how, the quality and the relevance of its solutions and the continuous support provided to its customers to help them improve their operational performance, a critical issue in the world of medical imaging. We are delighted to invest alongside EDL’s founders and management and to contribute to the achievement of their development goals.”

Our others news

“Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.